Long-Term Outcomes of Patients With High-Risk Prostate Cancer Treated With HDR Brachytherapy Boost

被引：0
|
作者：
Chang, A. J. [1 ]
Roach, M. [1 ]
Gottschalk, A. [1 ]
Cunha, A. J. [1 ]
Seymour, Z. A. [1 ]
Johnson, J. A. [1 ]
Raleigh, D. [1 ]
Shinohara, K. [1 ]
Hsu, I. J. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1406
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2598
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [41] Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy
    Vargas, Carlos
    Swartz, Douglas
    Vashi, Apoorva
    BIasser, Mark
    Kasareian, Ali
    Cesaretti, Jamie
    Kiley, Kathleen
    Terk, Mitchell
    [J]. BRACHYTHERAPY, 2013, 12 (02) : 120 - 125
  • [42] The impact of prostate volume on clinical outcomes in patients with localized prostate cancer treated with HDR boost
    Vigneault, E.
    Despres, P.
    Lavallee, M. C.
    Martin, A. G.
    Foster, W.
    Aubin, S.
    Beaulieu, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S74 - S74
  • [43] Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy
    Bittner, Nathan
    Merrick, Gregory S.
    Butler, Wayne M.
    Galbreath, Robert W.
    Lief, Jonathan
    Adamovich, Edward
    Wallner, Kent E.
    [J]. BRACHYTHERAPY, 2012, 11 (04) : 250 - 255
  • [44] Results of high dose rate (HDR) brachytherapy boost for prostate cancer
    Kelly, D
    Flynn, J
    Brookover, W
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S18 - S18
  • [45] Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer
    Tsumura, Hideyasu
    Satoh, Takefumi
    Ishiyama, Hiromichi
    Tabata, Ken-ichi
    Komori, Shouko
    Sekiguchi, Akane
    Ikeda, Masaomi
    Kurosaka, Shinji
    Fujita, Tetsuo
    Kitano, Masashi
    Hayakawa, Kazushige
    Iwamuro, Masatsugu
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2016, 8 (02) : 95 - 103
  • [46] Genitourinary (GU) Toxicity in Patients with Intermediate and High-Risk Prostate Cancer Managed with Hypofractionated External Radiation and High Dose Rate (HDR) Brachytherapy Boost
    Goel, A.
    Liu, C. M.
    Kaur, P.
    Wong, M. L.
    Scala, L. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E113 - E113
  • [47] HDR brachytherapy as a boost for intermediate and high risk prostate cancer: Longterm outcome of 2028 implants
    Kurek, R
    Martin, T
    Buhleier, T
    Dannenberg, T
    Baltas, D
    Zamboglou, N
    Tunn, UW
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 314 - 314
  • [48] HDR Brachytherapy boost irradiation in the radiotherapy (RT) of intermediate and high risk localised prostate cancer
    Agoston, P
    Major, T
    Somogyi, A
    Baricza, K
    Szasz, K
    Lövey, J
    Németh, G
    Kasler, M
    Fodor, J
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S4 - S5
  • [49] Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer
    Agarwal, Manuj
    Chhabra, Arpit M.
    Amin, Neha
    Braccioforte, Michelle H.
    Molitoris, Jason K.
    Moran, Brian J.
    [J]. BRACHYTHERAPY, 2018, 17 (06) : 882 - 887
  • [50] Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer
    Crook, Juanita
    [J]. BRACHYTHERAPY, 2015, 14 (02) : 142 - 147
12345